From on Medscape

Coverage from the

American Heart Association (AHA) Scientific Sessions 2018

November 10 - 12, 2018; Chicago, Illinois

November 10 - 12, 2018 Chicago, Illinois

Meeting Highlights At A Glance

  • xxTitlexx Top News From AHA 2018: Slideshow Highlights include new guidelines on cholesterol management and physical activity, plus potentially practicing changing results with high-dose omega-3 for CVD prevention.

Conference News

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.



Bloggers from the Floor

  • Think You're Immune From Bias? Think Again John Mandrola, MD, is intrigued by two studies at AHA that track the cognitive and financial biases that may influence what physicians do in practice and how they write and read research papers.
  • ENCORE-VT: Noninvasive Ablation of VT Could Disrupt EP A small study suggests that ventricular arrhythmia may be treated without the need for catheters and anesthesia. John Mandrola, MD, is impressed with the findings and the investigators' lack of hyperbole.
  • Pure Fish Oil Lowers CVD Risk Even If We Don’t Understand How REDUCE-IT found that high-dose purified omega-3 fish oil reduced CV events even if the drug didn’t work as expected. Evidence-based practice means we should embrace these results, says John Mandrola, MD.
  • Mandrola Previews AHA 2018 Among the highlights for the upcoming American Heart Association Scientific Sessions are studies on omega-3, inflammation, a potential EP breakthrough, and yoga. Not to mention new lipid guidelines.
  • What's Needed After AHA 2018? ACTION A sparsely attended session on social determinants of health sounded very familiar to Melissa Walton-Shirley, MD. So if we know what to do to improve CV health, why haven’t we done it yet?
  • Glad Your EF Is Better, But Stay on Your Meds While the TRED-HF trial may not be great news for patients with dilated cardiomyopathy and recovered EF, at least it eases this physician's conscience about her reluctance to curtail pharmacotherapy.
  • Lipid Lollapalooza at AHA 2018 The release of the 2018 cholesterol guidelines and a bunch of lipid-oriented trials made it a bountiful day at the American Heart Association meeting for Melissa Walton-Shirley, MD

Popular News from AHA 2017

Previous Coverage